nodes	percent_of_prediction	percent_of_DWPC	metapath
Telithromycin—CYP1A2—Carmustine—lymphatic system cancer	0.17	0.216	CbGbCtD
Telithromycin—CYP3A5—Teniposide—lymphatic system cancer	0.154	0.195	CbGbCtD
Telithromycin—CYP3A7—Vincristine—lymphatic system cancer	0.0986	0.125	CbGbCtD
Telithromycin—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0986	0.125	CbGbCtD
Telithromycin—CYP3A5—Vincristine—lymphatic system cancer	0.074	0.094	CbGbCtD
Telithromycin—CYP3A4—Cytarabine—lymphatic system cancer	0.0609	0.0773	CbGbCtD
Telithromycin—CYP3A4—Teniposide—lymphatic system cancer	0.0599	0.0762	CbGbCtD
Telithromycin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0419	0.0533	CbGbCtD
Telithromycin—CYP3A4—Vincristine—lymphatic system cancer	0.0289	0.0367	CbGbCtD
Telithromycin—Anorexia—Teniposide—lymphatic system cancer	0.000949	0.00445	CcSEcCtD
Telithromycin—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.000941	0.00442	CcSEcCtD
Telithromycin—Fungal infection—Methotrexate—lymphatic system cancer	0.000941	0.00442	CcSEcCtD
Telithromycin—Hypotension—Teniposide—lymphatic system cancer	0.00093	0.00436	CcSEcCtD
Telithromycin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000924	0.00433	CcSEcCtD
Telithromycin—Neutropenia—Carmustine—lymphatic system cancer	0.000921	0.00432	CcSEcCtD
Telithromycin—Arthralgia—Fludarabine—lymphatic system cancer	0.000913	0.00428	CcSEcCtD
Telithromycin—Myalgia—Fludarabine—lymphatic system cancer	0.000913	0.00428	CcSEcCtD
Telithromycin—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000892	0.00418	CcSEcCtD
Telithromycin—Confusional state—Fludarabine—lymphatic system cancer	0.000882	0.00414	CcSEcCtD
Telithromycin—Neutropenia—Vincristine—lymphatic system cancer	0.000879	0.00412	CcSEcCtD
Telithromycin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000875	0.0041	CcSEcCtD
Telithromycin—Decreased appetite—Teniposide—lymphatic system cancer	0.000865	0.00406	CcSEcCtD
Telithromycin—Vomiting—Mechlorethamine—lymphatic system cancer	0.000858	0.00403	CcSEcCtD
Telithromycin—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000858	0.00402	CcSEcCtD
Telithromycin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000856	0.00402	CcSEcCtD
Telithromycin—Stomatitis—Carmustine—lymphatic system cancer	0.000856	0.00401	CcSEcCtD
Telithromycin—Rash—Mechlorethamine—lymphatic system cancer	0.000851	0.00399	CcSEcCtD
Telithromycin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00085	0.00399	CcSEcCtD
Telithromycin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000846	0.00397	CcSEcCtD
Telithromycin—Flushing—Bleomycin—lymphatic system cancer	0.000838	0.00393	CcSEcCtD
Telithromycin—Anorexia—Fludarabine—lymphatic system cancer	0.000834	0.00391	CcSEcCtD
Telithromycin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00082	0.00385	CcSEcCtD
Telithromycin—Stomatitis—Vincristine—lymphatic system cancer	0.000817	0.00383	CcSEcCtD
Telithromycin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000814	0.00382	CcSEcCtD
Telithromycin—Nausea—Mechlorethamine—lymphatic system cancer	0.000802	0.00376	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000797	0.00374	CcSEcCtD
Telithromycin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000795	0.00373	CcSEcCtD
Telithromycin—Jaundice—Mitoxantrone—lymphatic system cancer	0.000795	0.00373	CcSEcCtD
Telithromycin—Urticaria—Teniposide—lymphatic system cancer	0.000791	0.00371	CcSEcCtD
Telithromycin—Glossitis—Methotrexate—lymphatic system cancer	0.000789	0.0037	CcSEcCtD
Telithromycin—Abdominal pain—Teniposide—lymphatic system cancer	0.000787	0.00369	CcSEcCtD
Telithromycin—Paraesthesia—Fludarabine—lymphatic system cancer	0.000786	0.00369	CcSEcCtD
Telithromycin—Hallucination—Carmustine—lymphatic system cancer	0.000784	0.00368	CcSEcCtD
Telithromycin—Oedema peripheral—Carmustine—lymphatic system cancer	0.000776	0.00364	CcSEcCtD
Telithromycin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000774	0.00363	CcSEcCtD
Telithromycin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00077	0.00361	CcSEcCtD
Telithromycin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000766	0.00359	CcSEcCtD
Telithromycin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00076	0.00357	CcSEcCtD
Telithromycin—Visual impairment—Carmustine—lymphatic system cancer	0.000759	0.00356	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000755	0.00354	CcSEcCtD
Telithromycin—Fatigue—Fludarabine—lymphatic system cancer	0.000754	0.00354	CcSEcCtD
Telithromycin—Hallucination—Vincristine—lymphatic system cancer	0.000748	0.00351	CcSEcCtD
Telithromycin—Constipation—Fludarabine—lymphatic system cancer	0.000748	0.00351	CcSEcCtD
Telithromycin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000746	0.0035	CcSEcCtD
Telithromycin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000739	0.00347	CcSEcCtD
Telithromycin—Eye disorder—Carmustine—lymphatic system cancer	0.000736	0.00346	CcSEcCtD
Telithromycin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000733	0.00344	CcSEcCtD
Telithromycin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000733	0.00344	CcSEcCtD
Telithromycin—Flushing—Carmustine—lymphatic system cancer	0.000731	0.00343	CcSEcCtD
Telithromycin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000727	0.00341	CcSEcCtD
Telithromycin—Anaemia—Bleomycin—lymphatic system cancer	0.000726	0.00341	CcSEcCtD
Telithromycin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000721	0.00338	CcSEcCtD
Telithromycin—Asthenia—Teniposide—lymphatic system cancer	0.000714	0.00335	CcSEcCtD
Telithromycin—Pruritus—Teniposide—lymphatic system cancer	0.000704	0.0033	CcSEcCtD
Telithromycin—Arrhythmia—Carmustine—lymphatic system cancer	0.000704	0.0033	CcSEcCtD
Telithromycin—Leukopenia—Bleomycin—lymphatic system cancer	0.000703	0.0033	CcSEcCtD
Telithromycin—Cardiac disorder—Vincristine—lymphatic system cancer	0.000698	0.00328	CcSEcCtD
Telithromycin—Mental disorder—Carmustine—lymphatic system cancer	0.00069	0.00324	CcSEcCtD
Telithromycin—Vaginal infection—Methotrexate—lymphatic system cancer	0.000686	0.00322	CcSEcCtD
Telithromycin—Malnutrition—Carmustine—lymphatic system cancer	0.000686	0.00322	CcSEcCtD
Telithromycin—Angiopathy—Vincristine—lymphatic system cancer	0.000683	0.0032	CcSEcCtD
Telithromycin—Diarrhoea—Teniposide—lymphatic system cancer	0.000681	0.0032	CcSEcCtD
Telithromycin—Myalgia—Bleomycin—lymphatic system cancer	0.000669	0.00314	CcSEcCtD
Telithromycin—Back pain—Carmustine—lymphatic system cancer	0.000664	0.00311	CcSEcCtD
Telithromycin—Mental disorder—Vincristine—lymphatic system cancer	0.000659	0.00309	CcSEcCtD
Telithromycin—Urine output increased—Methotrexate—lymphatic system cancer	0.000657	0.00308	CcSEcCtD
Telithromycin—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000657	0.00308	CcSEcCtD
Telithromycin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000654	0.00307	CcSEcCtD
Telithromycin—Confusional state—Bleomycin—lymphatic system cancer	0.000647	0.00303	CcSEcCtD
Telithromycin—Vision blurred—Carmustine—lymphatic system cancer	0.000647	0.00303	CcSEcCtD
Telithromycin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000645	0.00302	CcSEcCtD
Telithromycin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000641	0.00301	CcSEcCtD
Telithromycin—Anaemia—Carmustine—lymphatic system cancer	0.000634	0.00297	CcSEcCtD
Telithromycin—Back pain—Vincristine—lymphatic system cancer	0.000633	0.00297	CcSEcCtD
Telithromycin—Vomiting—Teniposide—lymphatic system cancer	0.000633	0.00297	CcSEcCtD
Telithromycin—Asthenia—Fludarabine—lymphatic system cancer	0.000628	0.00294	CcSEcCtD
Telithromycin—Rash—Teniposide—lymphatic system cancer	0.000628	0.00294	CcSEcCtD
Telithromycin—Dermatitis—Teniposide—lymphatic system cancer	0.000627	0.00294	CcSEcCtD
Telithromycin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000625	0.00293	CcSEcCtD
Telithromycin—Headache—Teniposide—lymphatic system cancer	0.000624	0.00293	CcSEcCtD
Telithromycin—Pruritus—Fludarabine—lymphatic system cancer	0.000619	0.0029	CcSEcCtD
Telithromycin—Back pain—Mitoxantrone—lymphatic system cancer	0.000617	0.00289	CcSEcCtD
Telithromycin—Leukopenia—Carmustine—lymphatic system cancer	0.000614	0.00288	CcSEcCtD
Telithromycin—Anorexia—Bleomycin—lymphatic system cancer	0.000611	0.00287	CcSEcCtD
Telithromycin—Anaemia—Vincristine—lymphatic system cancer	0.000605	0.00284	CcSEcCtD
Telithromycin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000601	0.00282	CcSEcCtD
Telithromycin—Polyuria—Methotrexate—lymphatic system cancer	0.000601	0.00282	CcSEcCtD
Telithromycin—Hypotension—Bleomycin—lymphatic system cancer	0.000599	0.00281	CcSEcCtD
Telithromycin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000599	0.00281	CcSEcCtD
Telithromycin—Nausea—Teniposide—lymphatic system cancer	0.000591	0.00277	CcSEcCtD
Telithromycin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000589	0.00277	CcSEcCtD
Telithromycin—Vertigo—Vincristine—lymphatic system cancer	0.000588	0.00276	CcSEcCtD
Telithromycin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000587	0.00275	CcSEcCtD
Telithromycin—Leukopenia—Vincristine—lymphatic system cancer	0.000586	0.00275	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000584	0.00274	CcSEcCtD
Telithromycin—Myalgia—Carmustine—lymphatic system cancer	0.000584	0.00274	CcSEcCtD
Telithromycin—Anxiety—Carmustine—lymphatic system cancer	0.000582	0.00273	CcSEcCtD
Telithromycin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000576	0.0027	CcSEcCtD
Telithromycin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000571	0.00268	CcSEcCtD
Telithromycin—Confusional state—Carmustine—lymphatic system cancer	0.000565	0.00265	CcSEcCtD
Telithromycin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000558	0.00262	CcSEcCtD
Telithromycin—Myalgia—Vincristine—lymphatic system cancer	0.000558	0.00262	CcSEcCtD
Telithromycin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000557	0.00261	CcSEcCtD
Telithromycin—Vomiting—Fludarabine—lymphatic system cancer	0.000556	0.00261	CcSEcCtD
Telithromycin—Rash—Fludarabine—lymphatic system cancer	0.000552	0.00259	CcSEcCtD
Telithromycin—Dermatitis—Fludarabine—lymphatic system cancer	0.000551	0.00259	CcSEcCtD
Telithromycin—Headache—Fludarabine—lymphatic system cancer	0.000548	0.00257	CcSEcCtD
Telithromycin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000543	0.00255	CcSEcCtD
Telithromycin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000543	0.00255	CcSEcCtD
Telithromycin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000541	0.00254	CcSEcCtD
Telithromycin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000534	0.00251	CcSEcCtD
Telithromycin—Anorexia—Carmustine—lymphatic system cancer	0.000534	0.0025	CcSEcCtD
Telithromycin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000529	0.00248	CcSEcCtD
Telithromycin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000525	0.00246	CcSEcCtD
Telithromycin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000524	0.00246	CcSEcCtD
Telithromycin—Hypotension—Carmustine—lymphatic system cancer	0.000523	0.00245	CcSEcCtD
Telithromycin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00052	0.00244	CcSEcCtD
Telithromycin—Nausea—Fludarabine—lymphatic system cancer	0.00052	0.00244	CcSEcCtD
Telithromycin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000517	0.00242	CcSEcCtD
Telithromycin—Shock—Mitoxantrone—lymphatic system cancer	0.000512	0.0024	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00051	0.00239	CcSEcCtD
Telithromycin—Urticaria—Bleomycin—lymphatic system cancer	0.00051	0.00239	CcSEcCtD
Telithromycin—Anorexia—Vincristine—lymphatic system cancer	0.000509	0.00239	CcSEcCtD
Telithromycin—Insomnia—Carmustine—lymphatic system cancer	0.000506	0.00238	CcSEcCtD
Telithromycin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000506	0.00237	CcSEcCtD
Telithromycin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000503	0.00236	CcSEcCtD
Telithromycin—Paraesthesia—Carmustine—lymphatic system cancer	0.000503	0.00236	CcSEcCtD
Telithromycin—Hypotension—Vincristine—lymphatic system cancer	0.000499	0.00234	CcSEcCtD
Telithromycin—Somnolence—Carmustine—lymphatic system cancer	0.000498	0.00234	CcSEcCtD
Telithromycin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000496	0.00233	CcSEcCtD
Telithromycin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000487	0.00229	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000487	0.00228	CcSEcCtD
Telithromycin—Decreased appetite—Carmustine—lymphatic system cancer	0.000487	0.00228	CcSEcCtD
Telithromycin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000486	0.00228	CcSEcCtD
Telithromycin—Insomnia—Vincristine—lymphatic system cancer	0.000483	0.00227	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000483	0.00227	CcSEcCtD
Telithromycin—Paraesthesia—Vincristine—lymphatic system cancer	0.00048	0.00225	CcSEcCtD
Telithromycin—Constipation—Carmustine—lymphatic system cancer	0.000479	0.00225	CcSEcCtD
Telithromycin—Breast disorder—Methotrexate—lymphatic system cancer	0.000477	0.00224	CcSEcCtD
Telithromycin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000475	0.00223	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000474	0.00222	CcSEcCtD
Telithromycin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000473	0.00222	CcSEcCtD
Telithromycin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000467	0.00219	CcSEcCtD
Telithromycin—Decreased appetite—Vincristine—lymphatic system cancer	0.000465	0.00218	CcSEcCtD
Telithromycin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000463	0.00217	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000461	0.00216	CcSEcCtD
Telithromycin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000461	0.00216	CcSEcCtD
Telithromycin—Fatigue—Vincristine—lymphatic system cancer	0.000461	0.00216	CcSEcCtD
Telithromycin—Asthenia—Bleomycin—lymphatic system cancer	0.00046	0.00216	CcSEcCtD
Telithromycin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000458	0.00215	CcSEcCtD
Telithromycin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000458	0.00215	CcSEcCtD
Telithromycin—Constipation—Vincristine—lymphatic system cancer	0.000457	0.00214	CcSEcCtD
Telithromycin—Pruritus—Bleomycin—lymphatic system cancer	0.000454	0.00213	CcSEcCtD
Telithromycin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000452	0.00212	CcSEcCtD
Telithromycin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000452	0.00212	CcSEcCtD
Telithromycin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000449	0.00211	CcSEcCtD
Telithromycin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000447	0.0021	CcSEcCtD
Telithromycin—Constipation—Mitoxantrone—lymphatic system cancer	0.000445	0.00209	CcSEcCtD
Telithromycin—Abdominal pain—Carmustine—lymphatic system cancer	0.000443	0.00208	CcSEcCtD
Telithromycin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000437	0.00205	CcSEcCtD
Telithromycin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000437	0.00205	CcSEcCtD
Telithromycin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000429	0.00201	CcSEcCtD
Telithromycin—Neutropenia—Methotrexate—lymphatic system cancer	0.000426	0.002	CcSEcCtD
Telithromycin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000426	0.002	CcSEcCtD
Telithromycin—Abdominal pain—Vincristine—lymphatic system cancer	0.000422	0.00198	CcSEcCtD
Telithromycin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000413	0.00194	CcSEcCtD
Telithromycin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000412	0.00194	CcSEcCtD
Telithromycin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000411	0.00193	CcSEcCtD
Telithromycin—Vomiting—Bleomycin—lymphatic system cancer	0.000408	0.00191	CcSEcCtD
Telithromycin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000407	0.00191	CcSEcCtD
Telithromycin—Infestation—Methotrexate—lymphatic system cancer	0.000407	0.00191	CcSEcCtD
Telithromycin—Rash—Bleomycin—lymphatic system cancer	0.000404	0.0019	CcSEcCtD
Telithromycin—Dermatitis—Bleomycin—lymphatic system cancer	0.000404	0.0019	CcSEcCtD
Telithromycin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000403	0.00189	CcSEcCtD
Telithromycin—Asthenia—Carmustine—lymphatic system cancer	0.000402	0.00188	CcSEcCtD
Telithromycin—Stomatitis—Methotrexate—lymphatic system cancer	0.000396	0.00186	CcSEcCtD
Telithromycin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000394	0.00185	CcSEcCtD
Telithromycin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000385	0.0018	CcSEcCtD
Telithromycin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000383	0.0018	CcSEcCtD
Telithromycin—Asthenia—Vincristine—lymphatic system cancer	0.000383	0.0018	CcSEcCtD
Telithromycin—Diarrhoea—Carmustine—lymphatic system cancer	0.000383	0.0018	CcSEcCtD
Telithromycin—Nausea—Bleomycin—lymphatic system cancer	0.000381	0.00179	CcSEcCtD
Telithromycin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000373	0.00175	CcSEcCtD
Telithromycin—Dizziness—Carmustine—lymphatic system cancer	0.00037	0.00174	CcSEcCtD
Telithromycin—Diarrhoea—Vincristine—lymphatic system cancer	0.000366	0.00172	CcSEcCtD
Telithromycin—Hepatitis—Methotrexate—lymphatic system cancer	0.000365	0.00171	CcSEcCtD
Telithromycin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000356	0.00167	CcSEcCtD
Telithromycin—Vomiting—Carmustine—lymphatic system cancer	0.000356	0.00167	CcSEcCtD
Telithromycin—Dizziness—Vincristine—lymphatic system cancer	0.000353	0.00166	CcSEcCtD
Telithromycin—Rash—Carmustine—lymphatic system cancer	0.000353	0.00166	CcSEcCtD
Telithromycin—Dermatitis—Carmustine—lymphatic system cancer	0.000353	0.00165	CcSEcCtD
Telithromycin—Visual impairment—Methotrexate—lymphatic system cancer	0.000352	0.00165	CcSEcCtD
Telithromycin—Headache—Carmustine—lymphatic system cancer	0.000351	0.00165	CcSEcCtD
Telithromycin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000345	0.00162	CcSEcCtD
Telithromycin—Eye disorder—Methotrexate—lymphatic system cancer	0.000341	0.0016	CcSEcCtD
Telithromycin—Vomiting—Vincristine—lymphatic system cancer	0.00034	0.00159	CcSEcCtD
Telithromycin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000339	0.00159	CcSEcCtD
Telithromycin—Rash—Vincristine—lymphatic system cancer	0.000337	0.00158	CcSEcCtD
Telithromycin—Dermatitis—Vincristine—lymphatic system cancer	0.000337	0.00158	CcSEcCtD
Telithromycin—Headache—Vincristine—lymphatic system cancer	0.000335	0.00157	CcSEcCtD
Telithromycin—Nausea—Carmustine—lymphatic system cancer	0.000333	0.00156	CcSEcCtD
Telithromycin—Angiopathy—Methotrexate—lymphatic system cancer	0.000331	0.00155	CcSEcCtD
Telithromycin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000331	0.00155	CcSEcCtD
Telithromycin—Immune system disorder—Methotrexate—lymphatic system cancer	0.00033	0.00155	CcSEcCtD
Telithromycin—Rash—Mitoxantrone—lymphatic system cancer	0.000328	0.00154	CcSEcCtD
Telithromycin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000328	0.00154	CcSEcCtD
Telithromycin—Headache—Mitoxantrone—lymphatic system cancer	0.000326	0.00153	CcSEcCtD
Telithromycin—Mental disorder—Methotrexate—lymphatic system cancer	0.00032	0.0015	CcSEcCtD
Telithromycin—Malnutrition—Methotrexate—lymphatic system cancer	0.000318	0.00149	CcSEcCtD
Telithromycin—Nausea—Vincristine—lymphatic system cancer	0.000317	0.00149	CcSEcCtD
Telithromycin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000311	0.00146	CcSEcCtD
Telithromycin—Nausea—Mitoxantrone—lymphatic system cancer	0.000309	0.00145	CcSEcCtD
Telithromycin—Back pain—Methotrexate—lymphatic system cancer	0.000307	0.00144	CcSEcCtD
Telithromycin—Vision blurred—Methotrexate—lymphatic system cancer	0.000299	0.0014	CcSEcCtD
Telithromycin—Anaemia—Methotrexate—lymphatic system cancer	0.000294	0.00138	CcSEcCtD
Telithromycin—Vertigo—Methotrexate—lymphatic system cancer	0.000285	0.00134	CcSEcCtD
Telithromycin—Leukopenia—Methotrexate—lymphatic system cancer	0.000284	0.00133	CcSEcCtD
Telithromycin—Myalgia—Methotrexate—lymphatic system cancer	0.000271	0.00127	CcSEcCtD
Telithromycin—Arthralgia—Methotrexate—lymphatic system cancer	0.000271	0.00127	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000269	0.00126	CcSEcCtD
Telithromycin—Confusional state—Methotrexate—lymphatic system cancer	0.000261	0.00123	CcSEcCtD
Telithromycin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000259	0.00122	CcSEcCtD
Telithromycin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000254	0.00119	CcSEcCtD
Telithromycin—Skin disorder—Methotrexate—lymphatic system cancer	0.000252	0.00118	CcSEcCtD
Telithromycin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000251	0.00118	CcSEcCtD
Telithromycin—Anorexia—Methotrexate—lymphatic system cancer	0.000247	0.00116	CcSEcCtD
Telithromycin—Hypotension—Methotrexate—lymphatic system cancer	0.000242	0.00114	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000236	0.00111	CcSEcCtD
Telithromycin—Insomnia—Methotrexate—lymphatic system cancer	0.000235	0.0011	CcSEcCtD
Telithromycin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000233	0.00109	CcSEcCtD
Telithromycin—Somnolence—Methotrexate—lymphatic system cancer	0.000231	0.00108	CcSEcCtD
Telithromycin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000228	0.00107	CcSEcCtD
Telithromycin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000225	0.00106	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000224	0.00105	CcSEcCtD
Telithromycin—Fatigue—Methotrexate—lymphatic system cancer	0.000224	0.00105	CcSEcCtD
Telithromycin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000214	0.001	CcSEcCtD
Telithromycin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000212	0.000995	CcSEcCtD
Telithromycin—Urticaria—Methotrexate—lymphatic system cancer	0.000206	0.000967	CcSEcCtD
Telithromycin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000205	0.000962	CcSEcCtD
Telithromycin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000191	0.000896	CcSEcCtD
Telithromycin—Asthenia—Methotrexate—lymphatic system cancer	0.000186	0.000873	CcSEcCtD
Telithromycin—Pruritus—Methotrexate—lymphatic system cancer	0.000183	0.000861	CcSEcCtD
Telithromycin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000177	0.000832	CcSEcCtD
Telithromycin—Dizziness—Methotrexate—lymphatic system cancer	0.000171	0.000805	CcSEcCtD
Telithromycin—Vomiting—Methotrexate—lymphatic system cancer	0.000165	0.000774	CcSEcCtD
Telithromycin—Rash—Methotrexate—lymphatic system cancer	0.000164	0.000767	CcSEcCtD
Telithromycin—Dermatitis—Methotrexate—lymphatic system cancer	0.000163	0.000766	CcSEcCtD
Telithromycin—Headache—Methotrexate—lymphatic system cancer	0.000162	0.000762	CcSEcCtD
Telithromycin—Nausea—Methotrexate—lymphatic system cancer	0.000154	0.000723	CcSEcCtD
